Nimetazepam
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Nimetazepam is a benzodiazepine with actions and adverse effects similar to those of diazepam. Nimetazepam is given orally for the short-term management of insomnia.
Indications
Nimetazepam is primarily indicated in conditions like Insomnia.
Contraindications
Nimetazepam is contraindicated in conditions like Myasthenia gravis, Narrow-angle glaucoma, Hypersensitivity.
Side Effects
The symptomatic adverse reactions produced by Nimetazepam are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Drowsiness, Irritability, Anorexia, Diarrhea, Nervousness, Tinnitus, Abdominal pain, Skin rashes, Confusion, Redness, Diaphoresis, Tremor, Nausea and vomiting, Stiffness, Excitation.
Warnings
Should be use with caution in patients with cardiac, hepatic, renal disorder, organic disorder in brain.
High Risk Groups
Drug should not be given to patients suffering from Liver Malfunction, and Geriatrics. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
No adult dosage information is recorded for this medicine yet.
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Nimetazepam was found.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No active brands are currently recorded for this generic.
2 records are present but flagged "Unverified / Legacy" and excluded.